PEers Enhancing Recovery (PEER)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Serious mental illness (SMI) is the second most costly disorder treated in the VHA, yet clinical outcomes for these patients in public sector settings are often poor due to a combination of low quality care and severe cognitive and functional impairments evidenced by this group. While these problems are multifaceted, studies outside the VHA have shown that using "consumer providers" (CPs) can improve and augment public care. Similar to recovering addiction counselors, CPs are individuals with SMI who use their lived experiences to provide services to others with SMI. CPs can reach out to patients that are difficult to engage, assist patients with tasks of daily living, offer a variety of rehabilitation (vocational, social, residential) services, be role models and offer hope for recovery, and facilitate support groups. Randomized controlled and quasi-experimental trials, all done outside the VHA, have shown that CPs can provide services that yield at least equivalent patient outcomes with particular benefits noted on intensive case management teams. Based on these successes both the President's New Freedom Commission and the Veteran Administration's Mental Health Strategic Plan call for broader dissemination of CPs as way to make mental health services more recovery-oriented, a recent national priority. Because of these recent calls, employing mentally ill veterans has just begun, although no effort has been made to evaluate their impact inside the VA mental health system. Yet its success outside the VHA and the recent emphasis on recovery-oriented care suggests the need to test this model in the VHA.
| Condition | Intervention |
|---|---|
|
Mental Disorder |
Behavioral: Adding a Consumer Provider to Intensive Case Management Teams (called MHICM in the VA) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Promoting Recovery Using Mental Health Consumer Providers |
- BASIS-24 [ Time Frame: 12 months prior to the intervention (BL1), immediately before the intervention (BL2), and 12 months post intervention (Post). ] [ Designated as safety issue: No ]
- Mental Health Recovery Measure (MHRM) [ Time Frame: 12 months prior to the intervention (BL1), immediately before the intervention (BL2), and 12 months post intervention (Post). ] [ Designated as safety issue: No ]
- Patient Activation Measure [ Time Frame: 12 months prior to the intervention (BL1), immediately before the intervention (BL2), and 12 months post intervention (Post). ] [ Designated as safety issue: No ]
- Recovery Assessment: Person in Recovery Version [ Time Frame: 12 months prior to the intervention (BL1), immediately before the intervention (BL2), and 12 months post intervention (Post). ] [ Designated as safety issue: No ]
- Illness Management and Recovery Scale: Client Self-Rating [ Time Frame: 12 months prior to the intervention (BL1), immediately before the intervention (BL2), and 12 months post intervention (Post). ] [ Designated as safety issue: No ]
- Quality of Life Interview, Brief Version [ Time Frame: 12 months prior to the intervention (BL1), immediately before the intervention (BL2), and 12 months post intervention (Post). ] [ Designated as safety issue: No ]
| Enrollment: | 285 |
| Study Start Date: | April 2008 |
| Study Completion Date: | January 2012 |
| Primary Completion Date: | April 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Arm 1
Adding a Consumer Provider to Intensive Case Management Teams (called MHICM in the VA)
|
Behavioral: Adding a Consumer Provider to Intensive Case Management Teams (called MHICM in the VA)
Adding a Consumer Provider to Intensive Case Management Teams (called MHICM in the VA)
|
|
No Intervention: Arm 2
Care as usual
|
Show Detailed Description
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient must have a Serious Mental Illness;
- Patient must be working with a VA Intensive Case Management team
Exclusion Criteria:
- Prior exposure to intervention; Reduced capacity;
- Patient is no longer working with a VA Intensive Case Management
Contacts and Locations| United States, California | |
| VA Medical Center, Loma Linda | |
| Loma Linda, California, United States, 92357 | |
| Long Beach | |
| Long Beach, California, United States, 90822 | |
| VA San Diego Healthcare System, San Diego | |
| San Diego, California, United States, 92161 | |
| VA Greater Los Angeles Healthcare System, West Los Angeles, CA | |
| West Los Angeles, California, United States, 90073 | |
| United States, Indiana | |
| Richard Roudebush VA Medical Center, Indianapolis | |
| Indianapolis, Indiana, United States, 46202-2884 | |
| United States, Nevada | |
| VA Southern Nevada Healthcare System, North Las Vegas, NV | |
| Las Vegas, Nevada, United States, 89106 | |
| United States, Pennsylvania | |
| Mental Illness Research, Education, and Clinical Center | |
| Pittsburgh, Pennsylvania, United States, 15206 | |
| Principal Investigator: | Matthew J. Chinman, PhD | Mental Illness Research, Education, and Clinical Center |
| Principal Investigator: | Amy N. Cohen, PhD | VA Greater Los Angeles Healthcare System, West Los Angeles, CA |
More Information
Additional Information:
Publications:
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00781079 History of Changes |
| Other Study ID Numbers: | IIR 06-227 |
| Study First Received: | October 27, 2008 |
| Last Updated: | April 18, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by Department of Veterans Affairs:
|
Organization Innovation Opinion Leaders Schizophrenia |
Additional relevant MeSH terms:
|
Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on May 21, 2013